Top Low Price Stocks To Buy For 2014

These are dark times for developed economies such as the United States and parts of Europe. Income inequality has been rising steadily for the last 40 years, but the 2008 financial crisis, the ensuing global recession and subsequent stimulus by the global central banks have only  exacerbated the divide between the rich and poor.

According to a recent study on income inequality by the National Bureau of Economic Research, the US now has the highest income inequality and lowest upward mobility of any country in the developed world. Accordingly, the study found that while the picture grows increasingly bleak for America’s middle class, “the share of total annual income received by the top 1 percent has more than doubled from 9 percent in 1976 to 20 percent in 2011.”

Earlier this year, a report by the Organization for Economic Co-operation and Development (OECD) also found that the US now leads the developed industrialized world in income ineq uality. Finally, a recent study from the University of California, Berkeley, found that 95 percent of income gains from 2009 to 2012 went to the top 1 percent of the earners, a trend largely attributed to the Federal Reserve’s asset purchases, since the rich hold a much larger proportion of financial assets than other income brackets.

Top Low Price Stocks To Buy For 2014: MWI Veterinary Supply Inc.(MWIV)

MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on MWI Veterinary Supply (Nasdaq: MWIV  ) , whose recent revenue and earnings are plotted below.

  • [By Rupert Hargreaves]

    Pet-related companies are highly sought after
    Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV  ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis — greater demand for animal treatments will lead to more demand for the distribution of animal health products.

Top Low Price Stocks To Buy For 2014: NanoViricides Inc (NNVC)

NanoViricides, Inc., incorporated on April 1, 2005, is a development-stage company. The Company is a nano-biopharmaceutical (nanomedicine) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections. The Company has several drugs in various stages of early development. The Company’s drugs are based on several patents, patent applications, provisional patent applications, and other property held by TheraCour Pharma, Inc. (TheraCou), to which the Company has exclusive licenses in perpetuity for the treatment of human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Influenza including Asian Bird Flu Virus (INF), Herpes Simplex Virus (HSV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Rabies. As of June 30, 2012, the Company had six drug development programs: Oral FluCideTM, against all Influenzas; a Piggy-back version of Flucide for hospitalized patien ts; nanoviricide eye drops against adenoviral EKC and herpes keratitis; HIVCide – I against HIV/AIDS; HerpeCide – I skin cream formulation for herpes cold sores and genital warts, and DengueCide, a broad spectrum nanoviricide designed to attack all types of dengue viruses and expected to be effective in the Severe Dengue Disease syndromes including Dengue Hemorrhagic Fever (DHS) and Dengue Shock Syndrome (DSS). As of June 30, 2012, it had engaged in organizational activities, sourcing compounds and materials, developing novel compounds and nanomaterials, and experimentation with studies on cell cultures and animals. In September 2011, NanoViricides Inc’s Inno-Haven LLC acquired a light industrial building.

The Company’s product development programs are divided into three sectors: commercially important diseases, neglected tropical diseases (NTD’s) and biosecurity/biodefense, and advanced technologies. The Company has collaborations with KARD Scientific, Inc., MA. and Southern Research Institute, AL for influenza viruse! s; National (Central) Institute of Hygiene and Epidemiology (NIHE) (Vietnam), for H5N1 avian flu; The Long Island Jewish Medical System, Feinstein Institute of Medical Research (LIJMS), NY and TheVac, LLC. for viral diseases of the eye (adenoviruses, herpesviruses – epidemic kerato-conjunctivitis (EKC), Herpes Keratitis); TheVac, LLC and Northeastern Ohio Medical University (NEOMED) for herpes virus infections; University of California at Berkeley for dengue hemorrhagic fever viruses; Center for Disease Control and Prevention (CDC) and National (Central) Institute of Hygiene and Epidemiology for rabies virus. The Company has developed lead drug candidates against a number of viral diseases.

The Company had consolidated all of its influenza drug programs into a single pan-influenza FluCide program. It is developing a single drug for all influenzas, whether pandemic, epidemic, seasonal, novel, emerging, human, swine, or avian. It is developing a nanoviricide agai nst adenoviral EKC. The nanoviricide eye drug candidate is formulated as simple eye drops. It is developing an anti-HSV nanoviricide skin cream formulation for direct application to the lesions. It has designed the anti-HIV nanoviricides using rational drug design principles. The ligands it has designed in the case of HIV-1 are thought to be broadly neutralizing. In-silico modeling indicates that its ligands dock to the conserved CD4 binding site of gp120 of HIV-1. The Company is working on developing anti-Dengue therapeutics. Dengue is an important NTD. Its RabiCide program has resulted in candidates that have enabled survival of 20% to 30% of infected animals after disease has set in, using a particular animal model.

The Company competes with Roche, Glaxo SmithKline, BioCryst Pharmaceuticals, Inc., Gilead, Bristol-Myers Squibb Company (BMS), Roche, Boehringer Ingelheim, Merck & Co., Inc. (Merck), Valeant, Schering, Pharmassett, Vertex, Intermune, Achillion and Novartis.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 nano-biopharmaceutical player that’s starting to trend within range of triggering a big breakout trade is Nanoviricides (NNVC), which engages in the discovery, development and commercialization of anti-viral therapeutics primarily in the U.S. This stock has been ripping to the upside so far in 2013, with share up big by 198%.

    If you take a look at the chart for Nanoviricides, you’ll notice that this stock has recently formed a double bottom chart pattern at $4.55 to $4.52 a share. Following that bottom, shares of NNVC have now started to uptrend and move within range of triggering a big breakout trade. That trade will hit if NNVC manages to take out the upper-end of its recent sideways trading chart pattern, which has seen NNVC trend between $4.55 and $5.74 a share.

    Traders should now look for long-biased trades in NNVC if it manages to break out above some near-term overhead resistance levels at Friday’s high of $4.94 a share to its 50-day moving average of $5.28 a share, and then once it takes out some more key overhead resistance levels at $5.72 to $5.74 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 234,994 shares. If that breakout triggers soon, then NNVC will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to its 52-week high at $7.59 a share.

    Traders can look to buy NNVC off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.55 to $4.52 a share. One can also buy NNVC off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Low Price Stocks To Buy For 2014: Sysco Corporation(SYY)

Sysco Corporation, through its subsidiaries, distributes food and related products primarily to the foodservice or food-away-from-home industry in North America and Europe. The company offers a line of frozen foods, such as meats, fully prepared entrees, fruits, vegetables, and desserts; a line of canned and dry foods; fresh meats, custom-cut fresh steaks, other meat, seafood, and poultry; dairy products; beverage products; imported specialties; and fresh produce. It also supplies various non-food items, including paper products, such as disposable napkins, plates, and cups; tableware, which include china and silverware; cookware comprising pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. In addition, the company offers personal care guest amenities, equipment, housekeeping supplies, room accessories, and textiles to the lodging industry. It serves restaurants, hospitals and nursing homes, schools and colleges, hotels and mote ls, lodging establishments, and other foodservice customers. Sysco Corporation was founded in 1969 and is headquartered in Houston, Texas.

Advisors’ Opinion:

  • [By Rich Smith]

    Only five privately held firms will participate in this two-year contract (extendable up to five years). No publicly traded firms at all were chosen to participate — but publicly traded firms did still win a few of the day’s smaller contracts, among them:

    A $76.1 million contract modification awarded to the Bell-Boeing Joint Project Office, a joint venture between Textron  (NYSE: TXT  ) and Boeing (NYSE: BA  ) , which instructs the JPO to delivery one single additional CV-22 tiltrotor aircraft to the U.S. Air Force by December 2016. A $39.4 million fixed-price with economic-price-adjustment contract for Sysco (NYSE: SYY  ) to provide “prime vendor food and beverage support” to the U.S. Army, Navy, Air Force, and Job Corps in Florida through April 16, 2019. A $32.3 million option exercise for NuStar Energy L.P. (NYSE: NS  ) subsidiary Shore Terminals LLC to provide “petroleum storage services” to the U.S. Army, Air Force, and Marine Corps through Nov. 30, 2016. A $7.7 million undefinitized contract modification compensating Lockheed Martin (NYSE: LMT  ) for “non-recurring sustainment activities” performed on behalf of the government of the United Kingdom, related to the latter’s purchase of F-35 Lightning II stealth fighter jets. This contract has a completion date of June 201

  • [By Selena Maranjian]

    For example, consider Bridgewater Associates, one of the world’s largest hedge fund companies. According to its recently released 13F statement, the company has reduced its positions in Hewlett-Packard Company (NYSE: HPQ  ) and Sysco Corporation (NYSE: SYY  ) , while eliminating its position in Valero Energy Corporation (NYSE: VLO  ) .

  • [By Dividends4Life]

    Related Articles:
    – W.W. Grainger, Inc. (GWW) Dividend Stock Analysis
    – The Clorox Company (CLX) Dividend Stock Analysis
    – Nucor Corporation (NUE) Dividend Stock Analysis
    – Sysco Corporation (SYY) Dividend Stock Analysis
    – More Stock Analysis

  • [By Jake L’Ecuyer]

    Sysco (NYSE: SYY) shares tumbled 1.97 percent to $34.39 after the company reported a drop in its fiscal second-quarter earnings.

    Mattel (NASDAQ: MAT) was down, falling 4.24 percent to $36.24 after B. Riley & Co downgraded the stock from Buy to Neutral and lowered the target price from $55 to $41.

Top Low Price Stocks To Buy For 2014: Swissquote Group Holding Ltd (SQN)

Swissquote Group Holding Ltd (Swissquote) is a provider of online financial and trading services in Switzerland. It operates an online bank that accepts deposits from its customers mainly in Swiss Francs, United States Dollars and Euros in current account form, as well as offers electronic dealing in shares, funds, options, warrants and bonds worldwide. Swissquote also provides stock brokerage services to self-directed investors and asset managers; custodian services against fees and foreign exchange; margin loans to customers against pledging of assets; fiduciary placements on behalf and at the risks of clients against commission fees and services to corporations for the management of their stock option programs, among others. Its financial portal swissquote.ch is an online platform providing the information that users need to conduct independent research on various investment vehicles. It is active domestically and abroad, including Dubai and Malta. Advisors’ Opinion:

  • [By Tom Stoukas]

    Swissquote Group Holding SA (SQN) surged 13 percent after agreeing to buy MIG Bank for an undisclosed price. Clariant AG lost 1.6 percent after UBS AG removed the maker of specialty chemicals from the list of its most preferred shares.

Top Low Price Stocks To Buy For 2014: Medifocus Inc (MDFZF)

Medifocus Inc.(Medifocus) is a Canada-based company. The Company is engaged in the business of development and commercialization of minimally invasive, focused-heat tumor targeted cancer treatment devices and systems. Medifocus operates through its wholly owned subsidiary, Celsion (Canada) Limited (Celsion). Celsion had purchased from Celsion Corporation (United States), all of the assets relating to breast cancer Microfocus APA 1000 System (System), consisting of the microwave machine, the adaptive phased array (APA) technology licensed from Massachusetts Institute of Technology (MIT). The Company focuses on breast cancer treatment by using microwave heating to enhance neoadjuvant chemotherapy to provide tumor shrinkage and control. Advisors’ Opinion:

  • [By EquityOptionsGuru]

    Over the past few years, and especially months, biotechnology stocks have been soaring on heightened investor expectations. Investors looking for a unique opportunity to participate in a massive bull rally over the next few years might want to pay special attention to one small but growing company called Medifocus (OTCMKTS:MDFZF).

  • [By Peter Graham]

    Small cap stocks KBridge Energy Corp (OTCMKTS: BMMCF), Medifocus Inc (OTCMKTS: MDFZF) and Inscor Inc (OTCMKTS: IOGA) have been getting some attention lately in various investment newsletters and some of it is deserved as the first stock sank 35% on Friday, the second one recently released its financials (which did show a big improvement, but there is also a big catch for investors) and the third one has been the subject of a very aggressive promotional campaign. But are any of these three small caps really all that hot for investors? Here is a quick reality check:

Top Low Price Stocks To Buy For 2014: Consumer Portfolio Services Inc.(CPSS)

Consumer Portfolio Services, Inc. operates as a specialty finance company in the United States. It engages in purchasing and serving retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company, through its automobile contract purchases, provides indirect financing to dealer customers for borrowers with limited credit histories, low incomes, or past credit problems. It serves as an alternative source of financing for dealers, allowing sales to customers who might not be able to obtain financing. The company also directly finances consumers for vehicle purchases. Consumer Portfolio Services, Inc. provides its automobile contracts through its headquarters and three servicing branches in Virginia, Florida, and Illinois. The company was founded in 1991 and is headquartered in Irvine, California.

Advisors’ Opinion:

  • [By Rick Munarriz]

    Finally, we have Consumer Portfolio Services (NASDAQ: CPSS  ) driving past where the pros were parked. Consumer Portfolio Services provides indirect automobile financing, primarily to folks with dodgy credit histories buying late-model used cars. This is a risky niche when the economy’s souring, but business is booming these days.

Top Low Price Stocks To Buy For 2014: Deckers Outdoor Corporation(DECK)

Deckers Outdoor Corporation engages in the design, manufacture, and marketing of footwear and accessories for outdoor activities and casual lifestyle use to men, women, and children. The company offers luxury footwear and accessories under the UGG brand name; high performance multi-sport shoes, rugged outdoor footwear, and sport sandals under the Teva brand name; casual and sustainable-lifestyle sneakers and accessories under the Simple brand name; casual footwear under the TSUBO brand name; and outdoor performance and lifestyle footwear under the Ahnu brand name. Its accessories include handbags and cold weather outerwear. The company sells its products primarily to specialty retailers, department stores, outdoor retailers, sporting goods retailers, shoe stores, and online retailers. Deckers Outdoor Corporation also sells its products directly to end-user consumers through its Web sites, call centers, retail concept stores, and retail outlet stores, as well as through ret ailers in the United States. In addition, the company distributes its products through independent distributors and retailers in Europe, Canada, Australia, Asia, and Latin America. It has a joint venture with Stella International Holdings Limited for the opening of retail stores and wholesale distribution for the UGG brand in China. Deckers Outdoor Corporation was founded in 1973 and is headquartered in Goleta, California.

Advisors’ Opinion:

  • [By Eric Volkman]

    Getty Images/Scott Olson The demise of Crocs (CROX), it seems, may have been greatly exaggerated. Remember the company’s signature product? Close to a decade ago, those colorful, clunky resin clogs were all the rage. The company that made them couldn’t sell the things fast enough, at one point reaching sales of 50 million pairs in 2007. Then fashion moved on, as it always does, and the economic slowdown started to bite into sales. Crocs plunged from a $168 million net profit in 2007 to a $185 million loss in 2008. In 2009, the company nearly ran out of cash and had a hard time making payroll. But Crocs’ fortunes have improved. In its most recent quarter, the firm posted a loss, but it was narrower than the market was expecting. And it’s found an investor that believes in its future — private equity giant Blackstone Group (BX), which recently provided a $200 million cash investment in return for a block of preferred shares eventually convertible into a stake of around 13 percent of the company. Perhaps the time has come to take those old clogs out of the closet, dust them off, and slip them on for a stroll. Stepping It Up Fashion is highly susceptible to consumer whim. The hot item is never hot for very long, and once consumers move on, it can be hard for the company to recover. In Crocs’ case, this was exacerbated by its limited product line — almost exclusively the clogs. The company learned from its mistakes. Since consumer tastes moved out of clog-land, Crocs has significantly broadened its product line to 300 styles. It now offers boots, flip-flops, deck shoes and slip-ons akin to the casuals from VF Corp.’s (VFC) Vans subsidiary. In terms of profitability, Crocs recovered quickly from its time in the fashion wilderness. From that 2008 bottom-line deficit of $185 million, the company sliced its loss to $42 million the following year, then stepped back into the black in 2010 (to the tune of $68 million). After two straight years of declines, revenue

  • [By DailyFinance Staff]

    Concerns about the political uncertainty in Ukraine caused some volatility in the markets Friday afternoon, with the major indexes making several U-turns ahead of the weekend. The Dow Jones industrial average (^DJI), which had been up by as much as 125 points, briefly dropped into loss territory before rebounding to end 49 points higher. The Standard & Poor’s 500 index (^GPSC) edged up 5 points, adding to Thursday’s record high, but the Nasdaq composite (^IXIC) lost 10 points. AP/Darko VojinovicPro-Russian militias have seized local government buildings in Crimea, Ukraine; the unrest there is making investors around the world nervous. February was a great month for investors. All three major averages jumped by about 4 percent. UnitedHealth Group (UNH) led the blue chips, gaining 1½ percent. Other health providers – Aetna (AET), Wellpoint (WLP), Cigna (CI) and Humana (HUM) — all gained between 1½ and 2 percent. And retail stocks remained active. Target (TGT) added another 3 percent. Best Buy rose 4 percent, and Fred’s (FRED), a regional department store chain, jumped 10 percent. But Pier 1 (PIR) fell 5½ percent after lowering its earnings outlook for a second time. That led to a series of brokerage downgrades. Decker Outdoor (DECK) tumbled 12 percent. The maker of footwear brands such as Ugg and Teva issued a weak outlook. And apparel maker Lululemon (LULU) fell 5-percent on negative comments from Credit Suisse. It seems as though there are always some big movers in the drug and biotech sectors – and that was certainly the case today. GW Pharmaceuticals (GWPH) rose 2 percent after the FDA granted orphan status to its drug to treat a rare form of childhood epilepsy. But most of the action was on the downside. Endologix (ELGX) slid 24 percent after forecasting lower revenue growth. Questcor (QCOR) fell 10 percent. It’s lost big for three straight days amid allegations of questionable business practices. Jazz Pharma

  • [By John Kell]

    Among the companies with shares expected to actively trade in Friday’s session are Deckers Outdoor Corp.(DECK), KBR Inc.(KBR) and Pier 1 Imports Inc.(PIR)

Top Low Price Stocks To Buy For 2014: Canadian Solar Inc.(CSIQ)

Canadian Solar Inc. engages in the design, development, manufacture, and sale of solar power products in Canada and internationally. The company offers solar cell and solar module products that convert sunlight into electricity for various uses. Its products include a range of standard solar modules for use in a range of residential, commercial, and industrial solar power generation systems. The company also designs and produces specialty solar modules and products consisting of customized modules that its customers incorporate into their products, such as solar-powered bus stop lighting; and specialty products, such as portable solar home systems and solar-powered car battery chargers. In addition, it sells solar system kits, a package consisting of solar modules produced by it and third party supplied components, such as inverters, racking system, and other accessories, as well as implements solar power development projects. The company sells its products under the Canad ian Solar brand name. Canadian Solar Inc. offers its standard solar modules through a direct sales force and sales agents primarily to distributors, system integrators, and original equipment manufacturer customers, as well as to solar projects; and specialty solar modules and products to the automotive, telecommunications, and light-emitting diode lighting sectors. The company was founded in 2001 and is based in Kitchener, Canada.

Advisors’ Opinion:

  • [By Jason Shubnell]

    Leading and Lagging Sectors
    Technology stocks gained Friday, with Parametric Sound (NASDAQ: PAMT) leading advancers after the company provided post merger update and outlook. Among the leading sector stocks, gains came from 21Vianet Group (NASDAQ: VNET), BlackBerry (NASDAQ: BBRY), Canadian Solar (NASDAQ: CSIQ), and Veeco Instruments (NASDAQ: VECO).
    In trading on Friday, utilities shares rose by just 0.06 percent. Among the sector stocks, Exterran Partners LP (NASDAQ: EXLP) was down more than 4.8 percent, while PG&E (NYSE: PCG) tumbled around 3.75 percent.
    Top Headline
    BlackBerry (NASDAQ: BBRY) posted a narrower-than-expected fourth-quarter loss.
    BlackBerry posted a quarterly net loss of $423 million, or $0.80 per share, versus a year-ago profit of $98 million, or $0.19 per share. Its loss from continuing operations came in at $423 million, or $0.80 per share, compared to a year-ago profit of $94 million, or $0.18 per share. BlackBerry’s adjusted loss from continuing operations came in at $0.08 per share.
    Its revenue slipped 64% to $976 million. However, analysts were estimating a loss of $0.56 per share on revenue of $1.17 billion. BlackBerry sold around 3.4 million smartphones in the quarter.
    Equities Trading UP
    Finish Line (NASDAQ: FINL) shares shot up 3.64 percent to $27.44 after the company posted better-than-expected fourth-quarter earnings.

  • [By James Brumley]

    Relative to its size, Canadian Solar (CSIQ) is the most overlooked of these solar stocks.

    Depending on the year in question, the company ranks anywhere from being in the top five to the top three suppliers in the world. And it supplies the whole world, with big, equitable demand from the United States, China, and Japan … three nations with lots of their own solar panel manufacturers, and a bent for protectionism. Canadian Solar simply muscles its way into key markets, generating sales growth of 27% in 2013.

Top Low Price Stocks To Buy For 2014: MicroChannel Technologies Corp (MCTC)

MicroChannel Technologies Corporation, incorporated on February 28, 2005, is a development-stage company. The Company is focused on the identification, acquisition, and development of new and potentially commercial opportunities.

As of August 31, 2013, the Company is not engaged in any business operations. As of August 31, 2013, the Company had no revenues.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks Bonamour Inc (OTCBB: BONI), Firstin Wireless Technology Inc (OTCMKTS: FINW) and Microchannel Technologies Corp (OTCBB: MCTC) have been attracting attention from variosu investment newsletters lately with at least two of these stocks being the subject of paid promotions. Of course, there is nothing wrong with properly disclosed paid promotions or investor relation types of activities as its up to investors and traders alike to do their due diligence. So how hot are these small cap stocks? Here is a quick reality check that might cool your appetite: